Nephros, Inc. (NEPH) Announces CEO Retirement and Succession Plan May 8, 2023 07:31AM
Nephros Announces CEO Retirement and Succession Plan May 8, 2023 07:30AM
Form SC 13D/A NEPHROS INC Filed by: WEXFORD CAPITAL LP Oct 26, 2020 04:42PM
Nephros, Inc. (NEPH) Names Andy Astor President and CEO Aug 14, 2020 07:31AM
Nephros Names Andy Astor President and Chief Executive Officer Aug 14, 2020 07:30AM


Aug 14, 2020 07:30AM Nephros Names Andy Astor President and Chief Executive Officer
Sep 6, 2018 07:30AM Specialty Renal Products Announces $3 Million Series A Financing
Jan 12, 2018 04:09PM Form SC 13D/A NEPHROS INC Filed by: WEXFORD CAPITAL LP
Jan 14, 2016 01:31PM Form SC 13D/A NEPHROS INC Filed by: WEXFORD CAPITAL LP
Dec 21, 2015 01:00PM Nephros, Inc. Completes Warrant Exercise Offer
Nov 20, 2015 01:03PM Nephros, Inc. Announces Offer to Exercise 2011 Warrants
Oct 5, 2015 05:06PM Form SC 13D/A NEPHROS INC Filed by: WEXFORD CAPITAL LP
Sep 30, 2015 07:30AM Nephros Announces Funding from Warrant Exercise by Wexford Capital and Plan to Temporarily Reduce Exercise Price for All Outstanding Warrants
Sep 9, 2014 04:08PM Form SC 13D/A NEPHROS INC Filed by: WEXFORD CAPITAL LP